• Sonali B. Pawar
• Sandesh S. Bole
• Saurbh N. Pawale
• Rakesh S. Nath

Alzheimer’s disease (AD) is one in all the foremost necessary neurodegenerative disorders within the twenty first century for the regularly aging population. Despite associate increasing range of patients, there are solely few medication to treat the malady. Alzheimer disease (AD) is that the most typical explanation for dementedness that affects quite forty four million people worldwide. It’s been detected that there’s solely symptomatic treatments are on the market to treat AD, however no cure exists. It’s a neurodegenerative malady characterized by Alois Alzheimer’s in 1906, and neuro chronic diseases are one in all the foremost issues facing by the trendy health care system. It’s a varied complicated malady that Pathology not clearly understood however it’s usually characterized by vegetative cell harm, memory pathology, etc. pathological Hallmark issue for Alzheimer malady is deposition of amyloid-β (Aβ) Plaques round the neurons, neurofibrillary tangles, and a decrease in neurotransmitter concentration and a few alternative neurochemical dysregulation. Differing kinds of risk factors like aerophilic stress, Obesity, diabetes, cardiovascular disease, pollution, smoking, hyper cholesterolemia etc. have a really vital role within the development of AD and within the development of its preventive measures. Workout and biological process factors are shown as protecting Measures for it and facilitate in its hindrance. For the identification of it, we have a tendency to Use body fluid biomarkers and antilepton emission pictorial representation Etc. Currently, there are 2 standard pharmacotherapies exist for AD that is approved by Food and Drug Administration (FDA) are Respectively- acetyl-cholinesterase inhibitors- tacrine, donepezil, Rivastigmine, galantamine and N-methyl-D-aspartate salt Antagonist (NMDA)-memantine.

Alzheimer’s, complications of Alzheimer’s, management, treatment, Alzheimer Dementess, Alzheimer’s malady

"COMPLICATIONS AND MANAGEMENT OF ALZHEIMER’S DISEASE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 12, page no.a637-a656, December-2021, Available :http://www.jetir.org/papers/JETIR2112077.pdf

"COMPLICATIONS AND MANAGEMENT OF ALZHEIMER’S DISEASE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 12, page no. ppa637-a656, December-2021, Available at : http://www.jetir.org/papers/JETIR2112077.pdf